Wednesday, Moderna (MRNA) exploded, soaring more than 100% after the company released positive topline results from its pivotal Phase 3 INTerpath-001 trial. In the study, Moderna’s individualized mRNA neoantigen therapy was combined with its partner Merck’s (MRK) Keytruda. When the two experimental drugs were combined, the Phase 3 study showed that the regimen significantly extended the time without the melanoma returning and significantly decreased the risk of the cancer spreading to other parts of the body. Melanoma is one of the deadliest forms of cancer and over 1.5 million Americans currently live with it.
Moderna Makes History
Moderna became prominent during the COVID-19 pandemic as one of the earliest vaccines approved. However, after a 20x move during the COVID-19 pandemic, shares have largely been left for dead, falling from a peak of $497 to $22.
Image Source: Zacks Investment Research
That said, Moderna is back on Wall Street’s radar as it becomes the first biotech company with a successful Phase 3 trial for a personalized, tumor-targeted MRNA cancer vaccine. Moderna’s melanoma drug uses its unique mRNA technology to sequence and target up to 34 patient-specific neoantigen , training T-cells to attack recurring tumor cells.
Wall Street Applauds Moderna
Following Wednesday’s news, several Wall Street analysts upgraded Moderna. For instance, William Blair analyst Myles Minter noted that the positive readout provides Moderna with a clear line of sight to revenue diversification beyond its legacy COVID-19 vaccine franchise.
Why are Moderna Shares Up So Much?
Moderna shares exploded for a few reasons. First, the early Phase 3 news was completely unexpected. Second, the drug diversifies Moderna’s one-dimensional portfolio nearly overnight. Third, before Wednesday, nearly 50 million shares, or 14.1% of the stock’s float were sold short. In other words, Moderna bears were forced to cover their shorts, adding fuel to the fire.
Extreme Demand
At the time of this writing, Moderna shares are up 130% as volume tracks 6,000% above the 50-day average – a sign of extreme demand.
Image Source: TradingView
Bottom Line
Moderna’s breakthrough marks a pivotal turning point for both oncology and the biotech industry at large. By successfully applying individualized mRNA technology to train the immune system against recurring tumor cells, Moderna and Merck have opened an extraordinary new frontier in targeted cancer treatment.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article.
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.